Biofrontera Stock Price

-0.22 (-6.29%)
Upgrade to Real-Time
Regular Market
Volume 162,503
Bid Price 3.30
Ask Price 3.34
News -
Day High 3.4184


52 Week Range


Day Low 3.20
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Biofrontera Inc BFRI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.22 -6.29% 3.28 10:09:43
Open Price Low Price High Price Close Price Prev Close
3.20 3.20 3.4184 3.50
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
651 162,503 $ 3.30 $ 537,027 - 2.2501 - 14.63
Last Trade Time Type Quantity Stock Price Currency
10:09:25 113 $ 3.28 USD


Draw Mode:

Biofrontera Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 50.74M 15.06M 7.06M $ 18.85M $ -18.76M -0.95 -1.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 133.79k -

more financials information »

Biofrontera News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BFRI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.684.842.873.862,161,532-1.40-29.91%
1 Month10.7910.792.876.875,815,446-7.51-69.6%
3 Months3.8714.632.25017.0918,814,045-0.59-15.25%
6 Months4.0914.632.25017.0718,335,842-0.81-19.8%
1 Year4.0914.632.25017.0718,335,842-0.81-19.8%
3 Years4.0914.632.25017.0718,335,842-0.81-19.8%
5 Years4.0914.632.25017.0718,335,842-0.81-19.8%

Biofrontera Description

Biofrontera Inc is a biopharmaceutical company specializing in the commercialization of pharmaceutical products for the treatment of dermatological conditions, diseases caused by exposure to sunlight that result in sun damage to the skin. Its licensed products focus on the treatment of actinic keratoses, which are skin lesions that can sometimes lead to skin cancer. It also markets a topical antibiotic for the treatment of impetigo, a bacterial skin infection.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.